https://www.taplowgroup.comInsight
https://www.taplowgroup.comTaplow
https://www.taplowgroup.comKnowledge
  • News
  • Cases
  • Downloads
Roundtable Conference in Beijing on 26 April 2019.
14.09.2019

Roundtable Conference in Beijing on 26 April 2019.

Taplow roundtable conference took place in Beijing on 26th April 2019, where 19 executives from various industries and fields participated. The...
Read more
Taplow listed in global survey for 5th consecutive year.
13.07.2019

Taplow listed in global survey for 5th consecutive year.

Commenting on Taplow featuring once again in one of the industries leading publications survey, Mark Firth, Managing Partner - UK and...
Read more
Taplow France launches Interim Management Services.
30.05.2019

Taplow France launches Interim Management Services.

Taplow Consulting France, Member of The Taplow Group, officially launched there new Interim Management service

Read more
First14151617181920212223Last

 CEO FOR A SPORTS:

Situation: A Finnish, mainly nationally operating sports company needed new CEO as the old one was about to retire. As sports business is one of the competence areas of our Finnish partner, we ended up delivering this search.

Read more …

For further Information please contac Timo Toivanen, Finland

 

 

 CEO FOR LOGISTICS:

Situation: One of the largest globally operating Logistics companies was in a need of new CIO for Finland. As Logistics and Value Chain is one of the competence areas of our Finnish partner, we ended up delivering this search.

Read more …

For further Information please contac Timo Toivanen, Finland

White Papers

  • India – The new R&D hub for Automotive

    Taplow India have conducted an in-depth review of the Automotive sector in India, For further information contact Sangeeta Sabharwal, India

    Click Here

  • Maysam Rizvi reviews the Banking Tech Revolution.

    Capital is more expensive, costs are higher and prices have gone down… the technology revolution has become a necessity.

    Click Here

  • EVOLVING BUSINESS UNITS Market Access thus becoming “transversal”

    The pharmaceutical market, in regards to the price component covered by the NHS, has been, until today, characterised by the presence of drugs of high therapeutic value, such as cancer-drugs, rheumatologic drugs, anti-infection drugs and drugs for the treatment of chronic illnesses, the vast majority of which have either seen their patent expire recently or will see it expire in the next two years.

    Click Here

  • BUSINESS CYCLES

    Present Human Capital Opportunities and Challenges:

    Click Here